INSM stock on watch after financing deals, common stock offering (NASDAQ:INSM)
seekingalpha.com
news
2022-10-19 13:06:51

Daniel Grizelj Updated to add common stock offering. Insmed Incorporated (NASDAQ:INSM), a biotech focused on rare diseases, announced in a regulatory filing on Wednesday two financing deals with certain investment funds to raise $500M via a term loan and royalty sales. In a press release, INSM also announced $275M of common stock offering with the sale of ~13.8M shares at $20.00 apiece. The underwritten offering is expected to close on October 21. The loan agreement with a group of funds managed by Pharmakon Advisors, LP provides the company with a $350M term loan that matures on October 29, 2027, and is payable in eight equal quarterly payments.
